ENTITY
Hutchison Whampoa

Hutchison Whampoa (13 HK)

205
Analysis
Industrials • Hong Kong
Hutchison Whampoa is an investment holding company with diverse global operations in ports and related services, property and hotels, retail, infrastructure, energy, and telecommunications. It operates port and container terminals, develops real estate, and provides mobile telecommunications services. The company is headquartered in Hong Kong and traces its roots back to 1862.
more
bullish•Hutchison Whampoa
•05 Aug 2026 14:29

Primer: Hutchison Whampoa (13 HK) - Aug 2026

CK Hutchison Holdings is a diversified global conglomerate with a strong presence in ports, retail, infrastructure, and telecommunications,...

Share
•11 Jan 2026 08:30

APAC Healthcare Weekly (January 11) – Hengrui, Hansoh, InSilico Medicine, Takeda, Hanmi Pharm

Hegrui got nod for new drug and Hansoh’s Ameile secured additional indication in China. InSilico entered $888M R&D collaboration. Takeda filed for...

Logo
338 Views
Share
•16 Mar 2025 08:30

APAC Healthcare Weekly (Mar 16)- Celltrion, Ono Pharma, Sun Pharma, Syngene, Zydus, Sichuan Kelun

APAC healthcare companies continued to get approvals for new products and initiates clinical trials. The companies continued with acquisitions and...

Logo
639 Views
Share
•05 Jan 2025 07:30

APAC Healthcare Weekly (Jan 5)- Beigene, Innovent Biologics, CSPC Pharma, Hutchmed, Yuhan, Lupin

APAC healthcare companies got approvals for new products as well as clinical trials. The companies continued with acquisitions and collaborations...

Logo
596 Views
Share
•24 Nov 2024 07:30

APAC Healthcare Weekly (Nov 24)- Samsung Biologics, Celltrion, Takeda, Kyowa Kirin, Astellas Pharma

​Samsung Biologics secures new manufacturing deals, Celltrion is acquiring iQone Healthcare, Takeda launches colorectal cancer drug in Japan, and...

Logo
1.2k Views
Share
x